CHIEU LE: Open Payments
NPI 1316495740 · POCASSET, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,280 in 52 payments from 11 companies in 2025. Trend: 2023 $4,572 · 2024 $3,060 · 2025 $3,280
Food & beverage: $3,280
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $557 |
| Otsuka America Pharmaceutical, Inc. | 13 | $553 |
| E.R. Squibb & Sons, L.L.C. | 7 | $477 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $443 |
| Alkermes, Inc. | 4 | $385 |
| Axsome Therapeutics, Inc. | 3 | $329 |
| Teva Pharmaceuticals USA, Inc. | 5 | $206 |
| ABBVIE INC. | 4 | $167 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: INVEGA SUSTENNA, COBENFY, CAPLYTA, REXULTI, Auvelity, ABILIFY MAINTENA, LYBALVI, UZEDY.
Industry payments across MA — which companies pay providers there.
